In one of the final steps before a marketing authorization decision by the European Medicines Agency, it recommended ...

Partnership is integral to GSK. Bringing people together is the best way to innovate and deliver products that transform the standard of care and improve lives. Over half of GSK’s clinical ...

Massachusetts, USA-based clinical stage biotech Rgenta Therapeutics, which is developing a new class of oral small molecules ...

GSK’sGSK2.90%increase; green up pointing triangle blood-cancer drug Blenrep showed positive overall survival data in a late-stage trial, increasing the likelihood for the treatment to return to ...

GlaxoSmithKline's COVID-19 products – antibody drug Xevudy and a vaccine adjuvant – helped drive a 5% increase in 2021 revenues to £34 billion ($46 billion), ahead of what chief executive ...

As one of the largest pharmaceutical and vaccine companies, GSK has used its vast resources ... five years (including joint ventures), with new products such as Shingrix and Arexvy offsetting ...

Nov 19 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Tuesday its experimental therapy, linerixibat, met its main goal in a late-stage trial to treat patients with a so-called ...

In 2021, GSK invested £5.3 billion in research and development (R&D), further growing a budget that has built a pipeline of 43 medicines and 21 vaccines, almost half of which address infectious ...